The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.
FDA Approves Drug for Chronic Drooling in Children
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment